Double blow to Pfizer’s emerging markets strategy
December 10, 2010Business Services, Sales and Marketing David Simmons, Ian Read, Jean-Michel Halfon, Jeffrey Kindler, Pfizer, Steve Yang, emerging pharma markets, recruitment
Pfizer has lost two senior executives with key roles in its emerging markets strategy. The departure of the company’s head …
Hormone therapy drugs ‘increase heart disease risk’
December 10, 2010Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen
Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …
Elan names Robert Ingram as new chairman
December 10, 2010Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing
Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …
Valuing medicines and NHS reform – the ABPI view
December 10, 2010Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing
For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …
Boehringer puts afatinib head-to-head with Herceptin
December 10, 2010Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer
Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …
SHL Establishes New Facility in the USA for Final Assembly and Packaging of Auto-Injectors
December 10, 2010Manufacturing and Production auto injector, autoinjector, final assembly, packaging, shl
SHL, a leading manufacturer of drug delivery devices, will further expand operations in the USA with the establishment of SHL …
Roche highlights R&D promise after setbacks
December 9, 2010Research and Development MS, Roche, oncology, personalised medicine, schizophrenia
Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …
First GP consortia named
December 9, 2010Sales and Marketing Lansley, NHS, consortia, reforms
The first consortia of GPs who will spearhead England’s healthcare reforms have been unveiled. A total of 52 consortia from …
Digital Pharma: AZ launches its first UK iPhone app
December 8, 2010Medical Communications Apple, AstraZeneca, Digital Pharma blog, apps, ipad, iphone
AstraZeneca has launched an iPhone app to provide UK healthcare professionals with information on genetic tests for lung cancer. The …
GSK acquires China’s Nanjing MeiRui Pharma for $70m
December 8, 2010Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing
GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …
William Vickery joins Hybrigenics
December 8, 2010Research and Development Hybrigenics, William Vickery, appointment, research and development
Paris-based biopharmaceutical company Hybrigenics has appointed William Vickery to the newly-created position of head of corporate and business development. He …
Astellas signs stem cell partnership in liver disease
December 8, 2010Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine
Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …
Out-of-hour procedures for clinical trials
December 8, 2010Research and Development GCP, Good Clinical Practice, Guy’s and St Thomas’ NHS Foundation Trust, Katherine Kennedy, clinical trials, trial safety
When a clinical trial subject is involved in a medical emergency, the hospital team need rapid access to information about …
NICE no for Avastin in breast cancer
December 8, 2010Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta
NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …
Contract research news in brief
December 8, 2010Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations
Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …
WPP launches Healix Digital Health
December 7, 2010Medical Communications Grey Healthcare, VML, WPP, digital marketing, digital marketing agency
A new digital healthcare agency, Healix Digital Health, has been launched by two companies within the WPP group. Grey Healthcare …
Trial hitch for Pfizer’s leukaemia drug submission plans
December 7, 2010Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia
Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …
WikiLeaks defends decision to publish critical facilities list
December 7, 2010Manufacturing and Production WikiLeaks, pharma manufacturing, security
Pharmaceutical facilities have featured prominently in in the latest batch of secret US embassy cables made public by WikiLeaks. The …
Takeda and Baxter make pandemic flu vaccine plans for Japan
December 7, 2010Manufacturing and Production Takeda, baxter, pharma manufacturing, vaccine manufacturing, vaccines
Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the …
AZ’s Brilique approved in Europe
December 7, 2010Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor
European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
